After identifying significant differences in the expression of selected miRNAs, we next focused on analyzing the frequency of immune checkpoints and their ligands on the surface of CD4 + T cells, CD8 + T cells, and CD19 + B cells to obtain a more comprehensive picture of the relationship between the miRNA profile and the immune status in patients with CLL. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.